Folgen der antidiabetischen Therapie
Andreas Kärber, Thomas Jansen(Ruhr University Bochum), Joachim Dissemond(Essen University Hospital), Elvir Cesko(Essen University Hospital), Nadine Voshege, Sarah Piel(Düsseldorf University Hospital), Julia Freise(Medizinische Hochschule Hannover), Lisa Rappoport
Cited by 3
Related Papers
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
|The Lancet Respiratory Medicine|2021|523
Fabry disease and the skin: data from FOS, the Fabry outcome survey
|British Journal of Dermatology|2007|178
Update on Immunologic Therapy With Anti–CTLA-4 Antibodies in Melanoma: Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management
|Seminars in Oncology|2010|170
Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency
|Nature Communications|2016|153